Carlson Capital Management Has Raised Its Abbott Labs (ABT) Stake; TRULY INTL HOLDINGS LTD ORD ORDINARY SHA (TRUHF) Shorts Decreased By 13.36%

Abbott Laboratories (NYSE:ABT) Logo

TRULY INTL HOLDINGS LTD ORD ORDINARY SHA (OTCMKTS:TRUHF) had a decrease of 13.36% in short interest. TRUHF’s SI was 9.15 million shares in April as released by FINRA. Its down 13.36% from 10.56M shares previously. The SI to TRULY INTL HOLDINGS LTD ORD ORDINARY SHA’s float is 0.62%. It closed at $0.331 lastly. It is down 0.00% since April 23, 2017 and is . It has underperformed by 11.55% the S&P500.

Carlson Capital Management increased Abbott Labs (ABT) stake by 927.12% reported in 2017Q4 SEC filing. Carlson Capital Management acquired 55,173 shares as Abbott Labs (ABT)’s stock rose 5.88%. The Carlson Capital Management holds 61,124 shares with $3.49M value, up from 5,951 last quarter. Abbott Labs now has $103.37B valuation. The stock decreased 1.15% or $0.69 during the last trading session, reaching $59.19. About 5.87 million shares traded. Abbott Laboratories (NYSE:ABT) has risen 34.85% since April 23, 2017 and is uptrending. It has outperformed by 23.30% the S&P500.

Since December 14, 2017, it had 1 buy, and 18 insider sales for $23.52 million activity. STARKS DANIEL J bought $2.43 million worth of Abbott Laboratories (NYSE:ABT) on Tuesday, February 27. 1,053 shares were sold by Bracken Sharon J, worth $62,056. $96,728 worth of stock was sold by BIRD ROGER on Wednesday, February 28. On Wednesday, March 7 the insider Watkin Jared sold $183,579. 6,284 shares were sold by Contreras Jaime, worth $375,381. $27,213 worth of stock was sold by PEDERSON MICHAEL J on Friday, February 16. 11,106 shares valued at $667,804 were sold by Fussell Stephen R on Wednesday, February 28.

Investors sentiment increased to 0.91 in 2017 Q4. Its up 0.04, from 0.87 in 2017Q3. It is positive, as 52 investors sold ABT shares while 558 reduced holdings. 123 funds opened positions while 430 raised stakes. 1.22 billion shares or 0.64% more from 1.21 billion shares in 2017Q3 were reported. Cincinnati Ins reported 1.89% in Abbott Laboratories (NYSE:ABT). Clifford Swan Invest Counsel Limited Liability reported 334,383 shares. Moreover, Covington Invest Advsrs has 0.77% invested in Abbott Laboratories (NYSE:ABT). Weiss Multi reported 0.07% in Abbott Laboratories (NYSE:ABT). Voya Invest Mngmt holds 800,561 shares or 0.09% of its portfolio. Fernwood Investment Management Ltd Liability holds 0.2% of its portfolio in Abbott Laboratories (NYSE:ABT) for 6,443 shares. 5,175 are held by Accredited. 1St Source Bankshares reported 0.24% stake. Ftb accumulated 23,845 shares or 0.13% of the stock. Brown Advisory invested in 683,266 shares. Cap Rech Investors stated it has 85.14M shares or 1.43% of all its holdings. Savings Bank Of The Ozarks stated it has 0.6% of its portfolio in Abbott Laboratories (NYSE:ABT). Pggm Invests holds 0.25% or 768,745 shares. Beaumont Fin Prns Ltd Liability reported 117,940 shares. Beacon Fincl holds 0.24% or 24,011 shares.

Among 25 analysts covering Abbott Laboratories (NYSE:ABT), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. Abbott Laboratories has $90 highest and $4 lowest target. $63.76’s average target is 7.72% above currents $59.19 stock price. Abbott Laboratories had 106 analyst reports since July 24, 2015 according to SRatingsIntel. The rating was downgraded by William Blair to “Market Perform” on Friday, January 29. The firm earned “Neutral” rating on Thursday, October 19 by Citigroup. The stock of Abbott Laboratories (NYSE:ABT) earned “Buy” rating by Deutsche Bank on Friday, July 21. The firm has “Outperform” rating by RBC Capital Markets given on Wednesday, March 1. On Thursday, July 23 the stock rating was maintained by RBC Capital Markets with “Outperform”. The firm has “Outperform” rating by RBC Capital Markets given on Friday, January 29. On Friday, July 21 the stock rating was maintained by Argus Research with “Buy”. The rating was maintained by RBC Capital Markets on Friday, October 9 with “Outperform”. The company was maintained on Friday, September 22 by Stifel Nicolaus. The firm has “Buy” rating given on Thursday, August 27 by Wells Fargo.

Truly International Holdings Limited, an investment holding company, makes, sells, and trades in liquid crystal display products and electronic consumer products. The company has market cap of $. It operates through two divisions, LCD Products and Electronic Consumer Products. It currently has negative earnings. The firm offers touch panel products and modules; compact camera modules; personal care products, including electric toothbrushes, blood glucose monitors, and blood pressure monitors; calculators and electronic components; printed and flexible circuit board panels, and plastic injection molding products for various applications; health care products; and fingerprint identification modules and electrical devices.

Abbott Laboratories (NYSE:ABT) Institutional Positions Chart